Stefanos Aivazidis Selected Research

Liver Extracts

11/2019

Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefanos Aivazidis Research Topics

Disease

2	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2018
1	Gaucher Disease (Gaucher's Disease) 12/2021
1	Lewy Body Disease (Lewy Body Dementia) 12/2021
1	Synucleinopathies 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Epilepsy (Aura) 10/2021
1	Cholestasis 11/2019
1	Fibrosis (Cirrhosis) 11/2019
1	Inflammation (Inflammations) 11/2019
1	Liver Diseases (Liver Disease) 11/2019
1	Proteostasis Deficiencies 02/2019
1	Down Syndrome (Down's Syndrome) 01/2019
1	Starvation 01/2019
1	Homocystinuria 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Neuroblastoma 01/2018

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 11/2019 - 02/2019
1	Glucosylceramidase (Glucocerebrosidase)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Superoxides (Superoxide)IBA 10/2021
1	C.I. direct red 80IBA 11/2019
1	Acrolein (Aqualin)IBA 11/2019
1	AldehydesIBA 11/2019
1	AntioxidantsIBA 11/2019
1	Liver ExtractsIBA 11/2019
1	Free RadicalsIBA 02/2019
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2019
1	SNARE Proteins (SNAREs)IBA 01/2019
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2018
1	SulfurIBA 01/2018
1	CystathionineIBA 01/2018
1	Taurine FDA Link 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	AcidsIBA 01/2018
1	ParaquatIBA 01/2018
1	ManebIBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018